IRCT20180506039549N1已完成3 期
Effect of Alendronate on Bone Densitometry in Osteoporetic Chronic Kidney Disease Stage 3a-3b
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 82
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Osteoporotic Patients with Chronic Kidney Disease
- •Patients over 18 years of Age
排除标准
- •Patients with hyperparathyroidism
- •Patients with hypoparathyroidism
- •Patients with normal Densitometry
研究者
相似试验
已完成
不适用
The effect of Alendronate on bone mineral density in the acetabulum and proximal femur after cementless total hip arthroplastyPost hip arthroplastyJPRN-UMIN000004847Juntendo University Nerima Hospital36
进行中（未招募）
不适用
Effect of alendronate on spontaneous osteoclastogenesis in postmenopausal osteoporosis - ALENDRONATEMedDRA version: 6.1Level: PTClassification code 10031285postmenopausal osteoporosisEUCTR2006-001796-37-ITAZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO30
已完成
不适用
Efficacy of Alendronate for the Prevention of Bone Loss in Calcar Region Following Total Hip Arthroplasty.Osteoarthritis of hip jointJPRN-UMIN000027501Yokohama City University90
已完成
4 期
Effects of long-acting alendronate on osteoporosis with impaired glucose metabolismOsteoporosisJPRN-UMIN000000987ational Hospital Organization, Kyoto Medical Center100
已完成
不适用
Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related OsteoporosisCystic FibrosisOsteoporosisNCT00004489University of North Carolina60